TMEM175: The Lysosomal Potassium Channel in Parkinson's Disease and Beyond
Explore the structure, function, and clinical significance of the TMEM175 gene, a key player in lysosomal homeostasis and a major genetic risk factor for Parkinson's disease.
Gene Information Card
| Symbol | TMEM175 |
|---|---|
| Full Name | Transmembrane Protein 175 |
| Gene Type | Protein Coding |
| Chromosomal Location | 4p16.3 |
| NCBI Gene ID | 84299 ncbi.nlm.nih.gov/gene/84299 |
| Ensembl ID | ENSG00000165458 |
| UniProt ID | Q9BSA9 |
| OMIM ID | 616660 |
| HGNC ID | 28814 |
| Aliases | MGC4618, FLJ20607 |
Description
The TMEM175 gene encodes a transmembrane protein that functions as a potassium (K+) channel on the lysosomal membrane. It is a critical component for maintaining lysosomal pH stability and membrane potential, which are essential for proper cellular waste degradation and autophagy. TMEM175 is highly expressed in the brain and has emerged as a significant genetic risk factor for Parkinson's disease (PD). Genome-wide association studies (GWAS) have identified common variants in TMEM175 that increase the risk of developing PD, while rare coding mutations have been linked to early-onset forms of the disease. The protein forms a unique potassium channel with a novel structure, distinct from other known potassium channels, making it a promising therapeutic target for neurodegenerative diseases.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Parkinson's Disease | Loss-of-function mutations (e.g., p.M393T) impair lysosomal K+ conductance, leading to lysosomal alkalinization, impaired autophagy, and accumulation of alpha-synuclein, a hallmark of PD. The common risk variant (p.Q65P) is associated with reduced TMEM175 function. | Strong genetic association from multiple GWAS and functional studies in cellular and animal models. ClinVar lists TMEM175 variants associated with Parkinson's disease. |
| Early-Onset Parkinson's Disease | Rare homozygous or compound heterozygous loss-of-function mutations (e.g., p.V65M, p.R65W) cause severe lysosomal dysfunction, leading to early-onset parkinsonism with a more aggressive disease course. | Case reports and functional studies demonstrating a causal link between rare TMEM175 mutations and early-onset PD. |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Brain | 18.2 | High |
| Kidney | 10.5 | Medium |
| Liver | 8.1 | Medium |
| Heart | 6.3 | Low |
| Lung | 4.8 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| SH-SY5Y (Neuroblastoma) | 15.4 | High expression; used as a model for neuronal function. |
| HEK293 (Embryonic Kidney) | 12.1 | Commonly used for heterologous expression and electrophysiology studies. |
| HeLa (Cervical Cancer) | 9.8 | Moderate expression; used in autophagy and lysosomal studies. |
| HepG2 (Liver Cancer) | 7.2 | Moderate expression; relevant for metabolic studies. |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| p.M393T (c.1178T>C) | Missense | ~1-2% in European populations; rare in Asian populations | Loss-of-function; reduces K+ conductance, impairs lysosomal acidification, and increases alpha-synuclein aggregation. Associated with increased PD risk. |
| p.Q65P (c.194A>C) | Missense | Common variant; ~30% allele frequency in Europeans | Hypomorphic; reduces TMEM175 function moderately. This is the primary risk variant identified in GWAS for PD. |
| p.V65M (c.193G>A) | Missense | Rare | Loss-of-function; causes severe lysosomal dysfunction and is linked to early-onset PD. |
| p.R65W (c.193C>T) | Missense | Rare | Loss-of-function; similar to V65M, associated with early-onset PD. |
Mutation functional classification
Loss of Function (LOF)
Most pathogenic TMEM175 mutations, including p.M393T and p.V65M, are loss-of-function. They impair the channel's ability to conduct potassium ions, leading to lysosomal alkalinization, defective autophagy, and accumulation of toxic protein aggregates. This is the primary mechanism for PD pathogenesis.
Gain of Function (GOF)
No clear gain-of-function mutations have been identified for TMEM175. The common risk variant p.Q65P is a hypomorph, meaning it has reduced but not absent function, rather than a gain-of-function.
Dominant Negative (DN)
While TMEM175 is thought to form a multimeric channel, evidence for a dominant-negative effect is limited. The PD risk variants are generally considered to act through haploinsufficiency or a recessive-like reduction in overall function, rather than a dominant-negative mechanism.
View complete mutation data:
Gene Ontology (GO)
| • Potassium channel activity | • Lysosomal membrane |
| • Lysosomal pH regulation | • Autophagy |
| • Cellular response to starvation | • Protein homodimerization activity |
Pathways
• Lysosomal acidification and ion homeostasis
• Autophagy (macroautophagy)
• Parkinson's disease pathway
• Endocytosis
Protein Summary
The TMEM175 protein is a 477-amino acid lysosomal potassium channel with a unique architecture, consisting of two tandem 6-transmembrane (TM) domains that form a single functional channel. It is a homodimer, and each subunit contributes to the pore. Unlike classical potassium channels, TMEM175 lacks a typical selectivity filter signature sequence, yet it is highly selective for K+ over Na+. The channel is constitutively active and is crucial for setting the lysosomal membrane potential and providing the electrical driving force for proton (H+) entry via the V-ATPase, thereby maintaining the acidic luminal pH required for lysosomal enzyme activity. TMEM175 also interacts with other lysosomal proteins and is involved in the fusion of autophagosomes with lysosomes. Its dysfunction leads to impaired clearance of cellular debris, particularly in neurons, contributing to neurodegeneration.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TMEM175 Knockout HEK293 Cell Line | EDJ-KQ3394 | Human | 84286 | Details Get a Quote |
| TMEM175 Knockout A-549 Cell Line | EDJ-KQ25087 | Human | 84286 | Details Get a Quote |
| TMEM175 Knockout HCT 116 Cell Line | EDJ-KQ25088 | Human | 84286 | Details Get a Quote |
| TMEM175 Knockout HeLa Cell Line | EDJ-KQ25089 | Human | 84286 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records